Picture of Odonate logo

ODTC Odonate Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for Odonate, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses3.0832.790.8115127
Operating Profit-3.08-32.7-90.8-115-127
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-3.08-32.7-89-112-126
Provision for Income Taxes
Net Income After Taxes-3.08-32.7-89-112-126
Net Income Before Extraordinary Items
Net Income-3.08-32.7-89-112-126
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-3.08-32.7-89-112-126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.582-6.09-18.2-20.2-19.2
Dividends per Share